February 22, 2023 at 12:19 pm

New online superstore surpasses Amazon and Walmart to become most downloaded app in US

A screenshot from Temu’s commercial unveiled during the Super Bowl on Sunday, February 12, encouraging consumers to “shop like a billionaire.” From Temu/YouTube A new online shopping platform linked to one of China’s top retailers has quickly become the most downloaded app in the United States, surpassing Amazon and Walmart. Now it’s looking to capitalize… [Read More]
February 21, 2023 at 9:23 pm

The Hot Housing Market… In the Metaverse

Real estate builders and investors are increasingly turning to the metaverse, the catch-all phrase for the growing conglomerate of immersive digital worlds where avatars work, play, and purchase goods. Much like in the real world, supply and demand play a role in the fixed-scale pricing for virtual parcels, which are bought and sold in cryptocurrency… [Read More]
February 21, 2023 at 4:37 pm

An Inside Look at Retail Earnings: Home Depot (HD)

Retail earnings kicked off with Home Depot announcing their results before todays open. World’s largest home improvement retailer, Home Depot (HD) beat earnings consensus reporting Q4 EPS of $3.30 vs $3.28 while Q4 revenues missed consensus for the first time since 2019, $35.83B vs $35.97B. The company provided FY23 guidance that indicated sales growth and… [Read More]
February 21, 2023 at 4:34 pm

An Inside Look at Retail Earnings: Walmart (WMT)

Retail earnings kicked off with Walmart announcing their results before today’s open. Grocery retailer Walmart (WMT), beat earnings and revenue consensus reporting Q4 EPS of $1.71 vs $1.52 and Q4 revenues $164.05B vs 159.76B. The company provided weak Q1 guidance that indicated EPS $1.25-1.30 ex-items vs FactSet $1.37 [29 est, $1.19-1.57]; includes an expected $0.03… [Read More]
February 17, 2023 at 3:49 pm

Corbus Pharmaceuticals Expands Oncology Pipeline; Enters Exclusive Licensing Agreement

Precision oncology company, Corbus Pharmaceuticals (Nasdaq: CRBP), will commercialize its clinical stage antibody drug, CRB-701, with CSPC Megalith Biopharmaceutical. CRB-701 is a next generation antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload. CSPC is currently investigating CRB-701 in a Phase 1 clinical trial to treat advanced… [Read More]
February 16, 2023 at 5:10 pm

Soligenix, Inc: Vital Vaccine Development Program has Potential to Address Future Marburg Virus Outbreaks

As Equatorial Guinea confirms the deaths of nine people in its first outbreak of Marburg virus, Soligenix, Inc.’s (Nasdaq : SNGX) work in developing critical public health solutions has become even more timely. Soligenix, a late-stage biopharmaceutical company, is advancing the only subunit (protein) vaccine platform shown to protect against potentially lethal Ebola and Marburg… [Read More]
February 16, 2023 at 2:48 pm

Fusion Pharmaceuticals Acquires Investigational New Drug

Fusion Pharmaceuticals (Nasdaq: FUSN) has broadened its oncology pipeline with the acquisition of a Phase 2 program for a radiopharmaceutical targeting metastatic castrate resistant prostate cancer from RadioMedix, Inc. The radiopharmaceutical, 225Ac-PSMA I&T, is a small molecule targeting prostate specific membrane antigen expressed on prostate cancers. Highlights The Phase 2 “TATCIST” clinical trial is evaluating… [Read More]
February 14, 2023 at 4:35 pm

Incannex Healthcare Achieves Interim Milestone in Phase 2 Psilocybin Clinical Trial

Australian pharmaceutical company, Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), has achieved its interim milestone of 29 patients completing primary endpoint assessments in a Phase 2 trial evaluating psilocybin-assisted psychotherapy for anxiety. Incannex is developing proprietary medicinal cannabinoid products and psychedelic medicine therapies for unmet medical needs. Psilocybin-assisted psychotherapy has shown promise in the treatment… [Read More]
February 13, 2023 at 10:32 am

Retail investors flock to small-cap AI firms as Big Tech battles for share

By Medha Singh (Reuters) – Retail investors are piling into small-cap firms that are into building artificial intelligence tools as companies including Google-parent Alphabet and Microsoft jostle to pull ahead in the race for the next big growth driver. The viral success of ChatGPT has turned the spotlight on AI on Wall Street, reminiscent of… [Read More]
February 10, 2023 at 9:06 pm

META’s Metaverse is Underperforming. Is This An Opportunity For Other Projects?

Despite opposition from investors and low user engagement, Mark Zuckerberg, CEO of META (formerly Facebook), remains committed to the company’s shift toward the metaverse. Despite this, the virtual reality (VR) and metaverse division, Reality Labs, incurred significant losses in the fourth quarter of 2023, with a loss of $4.3 billion and revenue of $727 million…. [Read More]
February 10, 2023 at 1:42 pm

Gracell Biotechnologies Receives FDA Clearance of IND Application for Phase 1b/2 Clinical Trial

Gracell Biotechnologies (Nasdaq: GRCL), a global clinical-stage biopharmaceutical company, has received FDA clearance for its IND application, clearing the company to initiate a clinical trial to evaluate an autologous CAR-T therapeutic candidate for the treatment of relapsed/refractory multiple myeloma (RRMM). Gracell’s lead candidate, GC012F, has demonstrated deep responses and a favorable safety profile across indications…. [Read More]